Glanbia has acquired Sterling Technology, a US-based manufacturer of dairy bioactive solutions derived from bovine colostrum, for $60 million plus deferred consideration.
Colostrum is an ingredient used in the growing immunity and gut health segments of the health and wellness market. It is well established in multiple markets, in particular Asia markets with a focus on pediatric and medical nutrition, dietary supplements, and sports nutrition. The acquisition will build on Glanbia Nutritionals’ offering in immunity solutions.
“The acquisition of Sterling Technology enhances our bioactive solutions portfolio to support our customers’ needs and growth ambitions,” said Glanbia Nutritionals CEO Brian Phelan. “We are excited to bring on board the Sterling team and their expertise with this highly beneficial ingredient.”
Founded in 1987, Sterling Technology is located in South Dakota.